Dan Groman - 16 Aug 2023 Form 4 Insider Report for Enfusion, Inc.

Role
Chief Technology Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Aug 2023
Net transactions value
-$170,716
Form type
4
Filing time
18 Aug 2023, 16:16:04 UTC
Previous filing
15 Aug 2023
Next filing
21 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +31,444 +26% $0.000000 150,862 16 Aug 2023 Direct F1
transaction ENFN Class A Common Stock Tax liability $104,744 -13,192 -8.7% $7.94 137,670 16 Aug 2023 Direct F2
transaction ENFN Class A Common Stock Award $0 +19,223 +14% $0.000000 156,893 17 Aug 2023 Direct F1
transaction ENFN Class A Common Stock Tax liability $65,972 -8,065 -5.1% $8.18 148,828 17 Aug 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").
F2 Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Shares to the reporting person; not an open market transaction.